Abstract Background Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving procedure for patients with refractory cardiogenic shock. The purpose of this study was to identify the predictors of mortality with VA-ECMO support. Methods We retrospectively analyzed 195 adult patients who received VA-ECMO for refractory cardiogenic shock at our center between 2016 and 2023. Results Hundred-one(51.8%) patients died on ECMO,35(17.9%) patients had ECMO weaning but did not survive hospital discharge while 59(30.3%) patients survived and were discharged. 152 (77.9%) patients received VA-ECMO after cardiac surgery. The non-survivors had more frequencies of chronic kidney disease (24.3% vs. 8.5%, p=0.01), atrial fibrillation (36.8% vs. 16.9%, p=0.006), previous cardiotomies (50% vs. 32.2%, p=0.02), higher SOFA score at ECMO initiation 14(11,16) vs. 9(8,11), p0.001, lesser SAVE score -3(-6,0) vs. 3(1,5), p0.001 and higher levels of arterial lactate at ECMO initiation10.15(6.9,14.2) vs. 5.8 (4.8,8.4), p0.001, then at 12 h 11.7(7.7,19.65) vs. 4.1(2.7,6.3), p0.001 and 24 h 7.65 (4.2,20) vs. 1.9(1.4,2.7), p0.001 compared to the survivors. Logistic multivariable regression analysis revealed that initial SOFA score (OR: 1.67,95%CI: 1.345-2.072, p0.001), blood lactate level at 24 h (OR: 1.78, 95%CI: 1.33-2.27, p0.012) and atrial fibrillation (OR: 6.48,95% CI: 1.93-67.27, p=0.002) were the independent predictors of hospital mortality. Conclusion VA-ECMO still carries a significantly high hospital mortality. Identifying the predictors of mortality helps to prognosticate patients, which may help in clinical decision-making.Multivariable regression analysis
Laimoud et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: